RecruitingNot ApplicableNCT07213648

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)


Sponsor

University of Virginia

Enrollment

136 participants

Start Date

Nov 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a mobile app-based program that helps people with Huntington's disease or Parkinson's disease manage anxiety. The app works by training people to interpret uncertain situations in a less threatening way. **You may be eligible if...** - You have a clinical (or genetic) diagnosis of Huntington's disease or Parkinson's disease - You are experiencing anxiety symptoms (measured by a standard questionnaire) - You are 21 years old or older - You live in the USA - You can read and understand English - You have regular access to a smartphone or tablet that can download the app **You may NOT be eligible if...** - You have significant cognitive decline that would prevent you from completing the program - You have active suicidal thoughts - You do not have a compatible internet-connected device Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMindTrails-Movement

CBM-I training app with active CBM-I training condition

OTHERWaitlist Control

Version of MindTrails-Movement app including surveys and list of support resources but without active CBM-I training component


Locations(1)

Univeristy of Virginia School of Nursing

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07213648


Related Trials